Select Page

ProCure is a restricted-access resource that supports ZERO-affiliated Australian paediatric oncology clinicians and pharmacists to navigate regulatory, governance and sponsor enquiry pathways for precision-guided therapies.

ProCure is an internal trial resource for eligible clinicians and pharmacists participating in the ZERO2 sub-project, “Improving Access to Targeted Therapies Recommended Through the ZERO2 Childhood Cancer Precision Medicine Study: A type 3 hybrid effectiveness-implementation trial”. Trial ID: ACTRN12626000025336

;

This resource was developed through a collaboration between the Kids Cancer Centre at Sydney Children’s Hospital, the ZERO Childhood Cancer Program at Children’s Cancer Institute Australia, and UNSW Implementation to Impact (I2I).

Access profiles for over 200 targeted medicines

Support via the Drug Access Navigator (DAN)

Search medicines by molecular targets and more

Medicine sponsor details

A registered-user forum to share experiences